期刊文献+

诱导化疗加同步放化疗与单纯同步放化疗治疗局部晚期非小细胞肺癌的临床疗效比较 被引量:6

下载PDF
导出
摘要 目的比较诱导化疗加同步放化疗与单纯同步放化疗治疗局部晚期非小细胞肺癌的临床疗效。方法分析165例接受同步化疗加三维适形放疗的局部晚期不能手术治疗的非小细胞肺癌患者,其中93例在同步化疗前接受了诱导化疗。结果接受了诱导化疗组的病人在总生存率(中位:1.9和1.3年,5年生存率24%和11%,P<0.001)和无远处转移生存率(5年率42%和23%,P=0.021)方面要好于无诱导化疗组;诱导化疗对腺癌或大细胞肺癌的总生存率有显著影响(5年生存率24%vs8%,P=0.003),但是对鳞癌没有差异。结论诱导化疗加同步放化疗对局部晚期不能手术治疗的肺腺癌和大细胞肺癌在生存率方面能有显著性的提高。
出处 《中外医疗》 2008年第16期44-45,共2页 China & Foreign Medical Treatment
  • 相关文献

参考文献6

  • 1林小萍,王庆生,刘新民.肺癌发病趋势及分析[J].天津医科大学学报,2000,6(2):129-132. 被引量:35
  • 2蔡勇,张珊文,尹先哲,刘长青,李东明,苏星.放射治疗同时化疗Ⅲ期非小细胞肺癌[J].中华放射肿瘤学杂志,2001,10(1):31-33. 被引量:28
  • 3王瑞芝,王春波,郭汝涛.不能手术的Ⅲ期非小细胞肺癌的综合治疗[J].中华放射肿瘤学杂志,2001,10(2):91-93. 被引量:44
  • 4[4]Curran WJ,Scott C,Langer C,et al.Phase Ⅲ comparision of sequential vs concurrent chemoradiation therapy for patientswith unresectable stage Ⅲ non2small2cell lung can-cer initial report of RTOG 9410[J].Proc Am Soc Clin Oncol,2000,19(6).
  • 5[5]Libshitz HI,McKenna RJ,Mountain CF.Patterns of medi-astinal metastases in bronchogenic carcinoma[J].Chest,1986,90:229~232.
  • 6[6]Line DH,Deeley TJ.The necropsy findings in carcinoma of the bronchus[J].Br J Dis Chest,1971,65:238~242.

二级参考文献12

共引文献102

同被引文献56

  • 1Sheng Chen,Yu-Ling Cheng,Shi-Ting Li,Yao-Jun Ni,Biao Gu.Effect analysis of chemoradiotherapy after operation in patients with stage ⅢA non-small cell lung cancer[J].Asian Pacific Journal of Tropical Medicine,2012,5(10):823-827. 被引量:6
  • 2吕长兴,刘俊,王家明,王常禄,郭金栋,潘方华,蒋杰.两周期诱导化疗后Ⅲ期非小细胞肺癌同步放化疗的疗效分析[J].中国肺癌杂志,2005,8(1):48-50. 被引量:13
  • 3Murakami M, Kuroda Y, Okamoto Y, et al. Neoadjuvant concurrent chemoradiotherapy followed by definitive high dose radiotherapy or surgery for operable thoracic esophagel carcinoma[J]. Clinical Investigation, 1998, 40(5): 1049-1059.
  • 4Karold J, Wanebo Arbin S, Glicksman Michael P. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced panereatic cancer[J]. Archives of Surgery, 2000, 135(1):81-87.
  • 5PiverMS, HowesAE, Suit HD, et al. Effect of HU on the radiation response of CH3 mouse mammary tumors[J]. Cancer, 1972, 29: 407-412.
  • 6Piver M S, Barlow J J, Webster J. Hydroxuurea and radiation therapy in advaeed cervical cancer[J]. American Journal of Obstetrics and Gynecology, 1974, 120(7):969-972.
  • 7Piver M S, Barlow J J, Vongtama V, et al. Hydroxuurea as a radi ation sensitizer in women with carcinoma of the uterine cervix[J]. American Journal of Obstetrics and Gynecology, 1977, 129(4): 379-383.
  • 8Piver M S, Barlow J J, Vongtama V, et al. Hydroxuurea: A radiation potentiator in carcinoma of the uterine cervix[J]. American Journal of Obstetrics and Gynecology, 1983, 147(7): 803-808.
  • 9Piver M S, Vongtama V, Emrich L J. Hydroxuurea plus pelvic radiation versus placebo plus pelvic radiation in surgically staged stage ⅢB cervical cancer[J]. Journal of Surgical Oncology, 1987, 35 (2): 129-134.
  • 10Piver M S, Khalil M, Emrich L J. Hydroxuurea plus pelvic irradiation versus placebo plus pelvic irradiation in nonsurgically staged stage ⅢB cervical cancer[J]. Journal of Surgical Oncology, 1989, 42(2): 120-125.

引证文献6

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部